Search Within
Document Type
507-20-0
Keyword:'507-20-0'
Showing 1-30 of 75 results for "507-20-0" within Technical Documents
Data Sheet - A8909
al., J. Biol. Chem., 247, 5850-5855,
(1972).
3. Utermann, G., et al., J. Biol. Chem., 257, 501-507,
(1982).
4. Lux, S.E., et al., J. Biol. Chem., 247, 7510-7518,
(1972).
5. Brewer, H.B., et
Data Sheet - SRP5072
stored in 20 mM MOPS, pH 7.5,
50 mM NaCl, 10 mM glutathione, 0.25 mM DTT,
0.1 mM PMSF, and 30% glycerol.
Molecular mass: ∼69 kDa
Purity: 70–95% (SDS-PAGE, see Figure 1)
Specific Activity: 507–687
Site-Specific Chromosomal Mutagenesis Using theTargeTron GeneKnockout System
10000
Fl
u
o
re
sc
en
ce
(
d
R
)
Cycles
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40
0
CHEMISCREEN™ MEMBRANE PREPARATION RECOMBINANT HUMAN CCR3 CHEMOKINE RECEPTOR
(2000). Chemokines induce eosinophil degranulation through CCR-3. J.
Allergy Clin. Immunol. 106: 507–513.
Fulkerson PC et al. (2006) A central regulatory role for eosinophils and the eotaxin/CCR3
Product Information Sheet - SE120087
nm)
Standard 1 (0 ng/mL) 2.85
Standard 2 (0.625 ng/mL) 2.43
Standard 3 (1.25 ng/mL) 1.97
Standard 4 (2.5 ng/mL) 1.40
Standard 5 (5 ng/mL) 0.95
Standard 6 (10 ng/mL) 0.52
Standard 7 (20 ng/mL) 0.29
Product Information Sheet - FLAAS
samples containing 2 × 10–12 to
8 × 10–5 moles/liter (or 10–12 to 4 × 10–5 grams/ml based
on a MW of 507 g/mole for the free acid). ATP is
consumed and light is emitted when luciferase
catalyzes the
Product Information Sheet - FLAA
samples containing 2 × 10–12 to
8 × 10–5 moles/liter (or 10–12 to 4 × 10–5 grams/ml based
on a MW of 507 g/mole for the free acid). ATP is
consumed and light is emitted when luciferase
catalyzes the
Product Information Sheet - FLAAM
samples containing 2 × 10–12 to
8 × 10–5 moles/liter (or 10–12 to 4 × 10–5 grams/ml based
on a MW of 507 g/mole for the free acid). ATP is
consumed and light is emitted when luciferase
catalyzes the
Product Information Sheet - FLAAB
samples containing 2 × 10–12 to
8 × 10–5 moles/liter (or 10–12 to 4 × 10–5 grams/ml based
on a MW of 507 g/mole for the free acid). ATP is
consumed and light is emitted when luciferase
catalyzes the
Product Information Sheet - SE120049
luteinizing
hormone and follicle-stimulating hormone surges. J.
Clin. Endocrinol. Metab., 1979; 49: 507-513.
9. Simpson, E.R., and MacDonald, P.C., in
Endocrinology of pregnancy. Williams, R.H., ed.
A Hands-On Guide to Ultrafiltration/Diafiltration Optimization using Pellicon®Cassettes
Retentate volume at end of 3.4X Concentration =
1724 L/3.4 = 507 L
• Permeate volume removed during 3.4X concentration
= 1724 L – 507 L = 1217 L
9
Average
Data Sheet - 77237
, X.M. et al., Biochem. Pharmacol., 44, 2131-2137 (1992).
Cohen, G.M. et al., J Immunol., 153, 507-516 (1994).
Pancreatic Islets
Buitrago, A. et al., Biochem. Biophys. Res. Commun., 79
Product Information Sheet - SE120102
Standard Optical Units (450 nm)
Standard 1 (0 ng/mL) 2.20
Standard 2 (2.5 ng/mL) 1.32
Standard 3 (5 ng/mL) 0.92
Standard 4 (10 ng/mL) 0.65
Standard 5 (20 ng/mL) 0.42
Standard 6 (40 ng/mL) 0.23
3. Read
Product Information Sheet - SE120084
luteinizing
hormone and follicle-stimulating hormone surges.
J. Clin. Endocrinol. Metab., 1979; 49: 507-513.
9. Simpson, E.R., and MacDonald, P.C.,
Endocrinology of pregnancy. in: Williams, R.H.,
ed
Poster: Rapid, Ultrafiltration-based Method for Purification of Monoclonal Antibodies from Hybridoma Supernatants
Slide 1
#507- Rapid, Ultrafiltration-based Method for Purification of Monoclonal Antibodies from Hybridoma Supernatants
Darshan K. Koticha, Christopher A. Barbagallo and Peter J. Rapiejko
Millipore
Phosphotyrosine HTRF® Assay
-6 -4 -2 0
0
1.0×10 4
2.0×10 4
3.0×10 4
4.0×10 4
Biotin-p-Tyr Log [uM]
H
TR
F
ra
tio
(6
60
/6
20
*1
00
00
)
0 50 100
Phosphotyrosine HTRF® Assay
0 15 30 45 60 75 90
0
5.0×10 3
1.0×10 4
1.5×10 4
2.0×10 4
2.5×10 4
Kinase Reaction Time (min)
H
TR
F
ra
tio
(6
60
/6
20
*1
Product Information Sheet - CS0220
Low 305 6.0 6.0
Medium 607 6.8
High 1,078 5.9
Low 99 15.7
Medium 308 16.5
High 507 5.0
Recovery
LTB4 concentrations were measured in a variety of
MultiScreen Solubility Filter Plate: Quantitative method to determine drug aqueous solubility
50
25
0
1, 1 2, 1 1, 2 2, 2 1, 3 2, 3
So
lu
bi
lit
y
(µ
M
)
Figure 6: Reproducibility Analysis for Ketoconazole
plate/day
120
100
80
Product Information Sheet -
X.M. et al., Biochem. Pharmacol., 44,
2131-2137 (1992).
Cohen, G.M. et al., J Immunol., 153, 507-
516 (1994).
Pancreatic Islets
Buitrago, A. et al., Biochem. Biophys. Res.
Commun., 79, 823
Product Information Sheet - M9319
Compound B
+ Na3VO4
A 0 Control 1 100 µM 100 µM 100 µM 100 µM
B 5 nmol Control 2 33.3 µM 33.3 µM 33.3 µM 33.3 µM
C 10 nmol Control 3 11.1 µM 11.1 µM
FlowCellect™ Chemokine Receptor CCR3 Surface Expression Identification kit
Yellow Fluorescence (YLW-HLog)
20
0
15
0
10
0
50
0
C
ou
nt
M1
10e0 10e1 10e2 10e3 10e4
Yellow Fluorescence (YLW-HLog)
20
0
15
0
10
0
50
0
C
ou
nt
Plot3:
Product Information Sheet - M9194
Compound B
+ Na3VO4
A 0 Control 1 100 µM 100 µM 100 µM 100 µM
B 5 nmol Control 2 33.3 µM 33.3 µM 33.3 µM 33.3 µM
C 10 nmol Control 3 11.1 µM 11.1 µM
Outstanding performance Purospher®STAR HPLC and UHPLC columns - EMD
separated on Purospher® STAR RP-18 endcapped
0
1
2
3
4
5
66
Intensity
[x=107]
0 2 4 6 8 10 12
Time [min]Time [min]
EIC 209; 253; 507 – All
Readycult Federal Register Final Rule October 2002
............................ 507, 525.2,
508.1, 505,
551.1.
26. Atrazine 2 ........................................................................................ 507, 525.2,
508.1, 505,
551.1.
hHCN1-HEK293 Recombinant Cell Line
cells for all other passages).
20
128
127
91 110
117 123
15 17 20 27 30 36 40
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Data Sheet - CLLS1045
Estrogen Receptor Expression by the Human
Breast Epithelial Cell Line, MCF-10A. Oncol. Rep.,
6 (3), 507-511 (1999).
11. Kadota, M. et al., Delineating Genetic Altgerations
for Tumor Progression in the
Brochure: Purospher STAR HPLC and UHPLC Columns
endcapped
0
1
2
3
4
5
6
Intensity
[x=107]
0 2 4 6 8 10 12
Time [min]
EIC 209; 253; 507 – All MS
EIC 197; 241; 483 – All
Product Information Sheet - PP0500
C
for 2 weeks or at –20 °C for up to 4 weeks. The trypsin
solution remains active for at least 3 freeze-thaw
cycles.
0
500
1000
1500
2000
2500
0 5 10
pDADMAC Pretreatment Performance Guide
ambient
and cold room conditions are shown in Figures 20 and
21 respectively.
Continued Precipitation
0
5
10
15
20
0 10 20 30 40 50 60 70
Tu
rb
id
it
Page 1 of 3